DF2755A, a novel non-competitive allosteric inhibitor of CXCR1/2, reduces inflammatory and post-operative pain (2016)
- Authors:
- Lopes, Alexandre H. - Universidade Federal de Minas Gerais (UFMG)
- Brandolini, Laura
- Aramini, Andrea
- Bianchini, Gianluca
- Silva, Rangel L. - Universidade Federal de Minas Gerais (UFMG)
- Zaperlon, Ana C. - Universidade Federal de Minas Gerais (UFMG)
- Verri Júnior, Waldiceu Aparecido - Universidade Estadual de Londrina (UEL)
- Alves Filho, José Carlos Farias
- Cunha, Fernando de Queiroz
- Teixeira, Mauro M. - Universidade Federal de Minas Gerais (UFMG)
- Allegretti, Marcello
- Cunha, Thiago Mattar
- USP affiliated authors: ALVES FILHO, JOSÉ CARLOS FARIAS - FMRP ; CUNHA, FERNANDO DE QUEIROZ - FMRP ; CUNHA, THIAGO MATTAR - FMRP
- Unidade: FMRP
- DOI: 10.1016/j.phrs.2015.11.005
- Subjects: DOR; COMPLICAÇÕES PÓS-OPERATÓRIAS; QUIMIOCINAS; NEUTRÓFILOS; QUIMIOTAXIA
- Language: Inglês
- Imprenta:
- Source:
- Título: Pharmacological Research
- ISSN: 1043-6618
- Volume/Número/Paginação/Ano: v. 103, p. 69-79, 2016
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: hybrid
- Licença: unspecified-oa
-
ABNT
LOPES, Alexandre H. et al. DF2755A, a novel non-competitive allosteric inhibitor of CXCR1/2, reduces inflammatory and post-operative pain. Pharmacological Research, v. 103, p. 69-79, 2016Tradução . . Disponível em: https://doi.org/10.1016/j.phrs.2015.11.005. Acesso em: 30 dez. 2025. -
APA
Lopes, A. H., Brandolini, L., Aramini, A., Bianchini, G., Silva, R. L., Zaperlon, A. C., et al. (2016). DF2755A, a novel non-competitive allosteric inhibitor of CXCR1/2, reduces inflammatory and post-operative pain. Pharmacological Research, 103, 69-79. doi:10.1016/j.phrs.2015.11.005 -
NLM
Lopes AH, Brandolini L, Aramini A, Bianchini G, Silva RL, Zaperlon AC, Verri Júnior WA, Alves Filho JCF, Cunha F de Q, Teixeira MM, Allegretti M, Cunha TM. DF2755A, a novel non-competitive allosteric inhibitor of CXCR1/2, reduces inflammatory and post-operative pain [Internet]. Pharmacological Research. 2016 ; 103 69-79.[citado 2025 dez. 30 ] Available from: https://doi.org/10.1016/j.phrs.2015.11.005 -
Vancouver
Lopes AH, Brandolini L, Aramini A, Bianchini G, Silva RL, Zaperlon AC, Verri Júnior WA, Alves Filho JCF, Cunha F de Q, Teixeira MM, Allegretti M, Cunha TM. DF2755A, a novel non-competitive allosteric inhibitor of CXCR1/2, reduces inflammatory and post-operative pain [Internet]. Pharmacological Research. 2016 ; 103 69-79.[citado 2025 dez. 30 ] Available from: https://doi.org/10.1016/j.phrs.2015.11.005 - Toll-like receptor 9 activation in neutrophils impairs chemotaxis and reduces sepsis outcome
- Superoxide anion-induced pain and inflammation depends on TNFα/TNFR1 signaling in mice
- The citrus flavanone naringenin reduces gout-induced joint pain and inflammation in mice by inhibiting the activation of NFκB and macrophage release of IL-1β
- Trans-chalcone attenuates pain and inflammation in experimental acute gout arthritis in mice
- Hesperidin methylchalcone suppresses experimental gout arthritis in mice by inhibiting NF-KB activation
- Toll like receptor 9 deficiency in neutrophil improves sepsis outcome preventing down-regulation of CXCR2
- Splenectomy increases neutrophil migration but does not affect mortality in lethal sepsis
- Pyrrolidine dithiocarbamate inhibits superoxide anion-induced pain and inflammation in the paw skin and spinal cord by targeting NF-kB and oxidative stress
- Differential regulation of oxidative stress and cytokine production by endothelin ETA and ETB receptors in superoxide anion-induced inflammation and pain in mice
- Bosentan, a mixed endothelin receptor antagonist, inhibits superoxide anion-induced pain and inflammation in mice
Informações sobre o DOI: 10.1016/j.phrs.2015.11.005 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
